For half a century, the University of Utah’s Anticonvulsant Drog Development (ADD) Program has been at the forefront of discovery, helping millions of people living with epilepsy and seizure disorders. Since its founding in 1975, ADD has become the longest-running National Institutes of Health-funded program of its kind, a national model for how dedicated research can change lives for the better.
